Seeking Alpha

Mylan (MYL +3.5%) says one of its subsidiaries has received approval for three antiretroviral...

Mylan (MYL +3.5%) says one of its subsidiaries has received approval for three antiretroviral therapies used to treat HIV/AIDS under the World Health Organization's Prequalification of Medicines Program.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)